PRMT8 and amyotrophic lateral sclerosis: These data provide evidence that in vivo loss of PRMT1 and PRMT8 function enhances mutant FUS toxicity, indicating a primary role for PRMT1 and PRMT8 in FUS-related ALS pathogenesis.